Anisodine Hydromide

氢溴酸樟柳碱

Report date: 2026/05/20 20:02:01

Base Information

Drug NameAnisodine Hydromide
Drug Alias NameAnisodine hydrobromide
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsAdrenergic receptor alpha-1 agonists
TargetsMuscarinic acetylcholine receptorAdrenergic receptors alpha-1
Therapy Area/IndicationsIschemic StrokePeripheral VasospasmOrganophosphate Poisoning +[6] 
Global Approved IndicationsPeripheral VasospasmOrganophosphate PoisoningTremor +[5] 
Approved Indications in ChinaPeripheral VasospasmOrganophosphate PoisoningTremor +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu First Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCapital Medical UniversityChengdu First Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokePeripheral VasospasmOrganophosphate Poisoning +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A